Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapiesFrances Rocamora, Nathan E. Lewis, Thomas R. Fuerst et al.|Biotechnology Advances|2023Cited by 50
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Thomas R. Fuerst, K. Li et al.|npj Vaccines|2025Cited by 7
Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike proteinXiaofeng Li, Thomas R. Fuerst|New Biotechnology|2023Cited by 3